±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 243  |  »Ø¸´: 2

haoyumomo

Òø³æ (СÓÐÃûÆø)

[ÇóÖú] άÆÕÇóÖú ÒÑÓÐ2È˲ÎÓë

14.57,47,49.7,70.1,132.6,138.4,151.9
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangkaibo123

ÈÙÓþ°æÖ÷ (Ö°Òµ×÷¼Ò)

kerry

ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
²éѯģʽ£ºÄ£ºý²éѯ
̼Æ×Êý¾ÝÊäÈ룺
°´´ÓСµ½´ó˳ÐòÊäÈ룬Êý×Ö¼äÓÃÓ¢Îİë½Ç¶ººÅ(,)·Ö¸ôÀýÈ磺
21.4,30.4,37.4,73.2,73.7,125.6,126.6,139.6,140.2,168.2

ÈܼÁÑ¡Ï
Æ¥ÅäÈݲ (Êý×Ö¸ñʽ£¬¿É×ÔÐÐÉ趨)
ÏàËÆ¶È£º   %(ÏàËÆ¶È>=50%)



²éѯ½á¹û£º¹²²éµ½22¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼)
1 .     tinidazole
    ÏàËÆ¶È:75%
Magnetic Resonance in Chemistry          2005          43          139-146
Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers
Teodorico C. Ramalho and Michael B¨¹hl
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
2 .     N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]-3-(2-nitro-1H-imidazolyl)propanesu]fonamide
C9H15ClN4O4S     ÏàËÆ¶È:75%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
3 .     2-(2-methyl-5-nitro-1H-imidazolyl)ethyl bromide
    ÏàËÆ¶È:71.4%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
4 .     1-(2-Bromoethyl)-2-methyl-5-nitro-1-imidazole
    ÏàËÆ¶È:57.1%
Molecules          2009          14          1483-1494
Synthesis of Novel Hybrid Molecules from Precursors With Known Antiparasitic Activity
Haythem A. Saadeh, Ibrahim M. Mosleh and Mohammad S. Mubarak
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
5 .     N,N'-diisopropyl-2,6-bis(aminomethyl)pyridinium bromide
C13H25N3Br2     ÏàËÆ¶È:57.1%
Journal of Heterocyclic Chemistry          2006          43          549-557
Facile preparation and the crystal structure of N,N'-dialkyl-2,6-pyridinedimethanaminium halide
Tohru Kobayashi,Tsuyoshi Yaita,Yumi Sugo,Hiroki Suda,Shinji Suzuki,Yuki Fujii and Yoshiharu Nakano
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
6 .     metronidazole
    ÏàËÆ¶È:57.1%
Magnetic Resonance in Chemistry          2005          43          139-146
Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers
Teodorico C. Ramalho and Michael B¨¹hl
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
7 .     secnidazole
    ÏàËÆ¶È:57.1%
Magnetic Resonance in Chemistry          2005          43          139-146
Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers
Teodorico C. Ramalho and Michael B¨¹hl
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
8 .     2-(2-methyl-5-nitro-1H-imidazolyl)ethyl iodide
C6H8IN3O2     ÏàËÆ¶È:57.1%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
9 .     N-methyl-2-(2-methyl-5-nitro-1H-imidazolyl)ethylamine
C7H10Cl2N4O2     ÏàËÆ¶È:57.1%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
10 .     1,2-dimethyl-1H-phosphole
    ÏàËÆ¶È:57.1%
Organic Magnetic Resonance          1973          5          161-162
Position specificity of 13C31P coupling constants for methyl substituents in phospholes and 2¡ªPhospholenes
L. D. Quin, S. G. Borleske and R. C. Stocks
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
11 .     1-(3-nitro-1,2,4-1H-triazolyl)-3-(2-methyl-5-nitro-1H-imidazolyl)propan-2-ol
C9H11N7O5     ÏàËÆ¶È:55.5%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
12 .     N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]-3-propanesultam
C9H14N4O4S     ÏàËÆ¶È:55.5%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
13 .     N-[2-(2-methyl-5-nitroimidazol-1H-yl)-ethyl]-N-methyltrifluoroacetamide
C9H11F3N4O3     ÏàËÆ¶È:55.5%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
14 .     compound 11
C8H14O     ÏàËÆ¶È:50%
Tetrahedron Letters          2003          44          7541-7544
Formation of (E) 1-alkoxy-1,3-butadienes from corresponding propargyl ethers; vicarious nucleophilic substitution in alkoxyallenes
Robert Łysek, Ewa Woźny, Tong Thanh Danh, Marek Chmielewski
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
Domyallbesttohaveahappylife.
2Â¥2013-12-12 22:04:39
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lifeliuyan

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
haoyumomo: ½ð±Ò+10 2013-12-13 10:56:39
²éѯ½á¹û£º¹²²éµ½22¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼)
1 .     tinidazole
    ÏàËÆ¶È:75%
Magnetic Resonance in Chemistry          2005          43          139-146
Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers
Teodorico C. Ramalho and Michael B¨¹hl
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
2 .     N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]-3-(2-nitro-1H-imidazolyl)propanesu]fonamide
C9H15ClN4O4S     ÏàËÆ¶È:75%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
3 .     2-(2-methyl-5-nitro-1H-imidazolyl)ethyl bromide
    ÏàËÆ¶È:71.4%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
4 .     1-(2-Bromoethyl)-2-methyl-5-nitro-1-imidazole
    ÏàËÆ¶È:57.1%
Molecules          2009          14          1483-1494
Synthesis of Novel Hybrid Molecules from Precursors With Known Antiparasitic Activity
Haythem A. Saadeh, Ibrahim M. Mosleh and Mohammad S. Mubarak
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
5 .     N,N'-diisopropyl-2,6-bis(aminomethyl)pyridinium bromide
C13H25N3Br2     ÏàËÆ¶È:57.1%
Journal of Heterocyclic Chemistry          2006          43          549-557
Facile preparation and the crystal structure of N,N'-dialkyl-2,6-pyridinedimethanaminium halide
Tohru Kobayashi,Tsuyoshi Yaita,Yumi Sugo,Hiroki Suda,Shinji Suzuki,Yuki Fujii and Yoshiharu Nakano
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
6 .     metronidazole
    ÏàËÆ¶È:57.1%
Magnetic Resonance in Chemistry          2005          43          139-146
Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers
Teodorico C. Ramalho and Michael B¨¹hl
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
7 .     secnidazole
    ÏàËÆ¶È:57.1%
Magnetic Resonance in Chemistry          2005          43          139-146
Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers
Teodorico C. Ramalho and Michael B¨¹hl
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
8 .     2-(2-methyl-5-nitro-1H-imidazolyl)ethyl iodide
C6H8IN3O2     ÏàËÆ¶È:57.1%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
9 .     N-methyl-2-(2-methyl-5-nitro-1H-imidazolyl)ethylamine
C7H10Cl2N4O2     ÏàËÆ¶È:57.1%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
10 .     1,2-dimethyl-1H-phosphole
    ÏàËÆ¶È:57.1%
Organic Magnetic Resonance          1973          5          161-162
Position specificity of 13C31P coupling constants for methyl substituents in phospholes and 2¡ªPhospholenes
L. D. Quin, S. G. Borleske and R. C. Stocks
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
11 .     1-(3-nitro-1,2,4-1H-triazolyl)-3-(2-methyl-5-nitro-1H-imidazolyl)propan-2-ol
C9H11N7O5     ÏàËÆ¶È:55.5%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
12 .     N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]-3-propanesultam
C9H14N4O4S     ÏàËÆ¶È:55.5%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
13 .     N-[2-(2-methyl-5-nitroimidazol-1H-yl)-ethyl]-N-methyltrifluoroacetamide
C9H11F3N4O3     ÏàËÆ¶È:55.5%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
14 .     compound 11
C8H14O     ÏàËÆ¶È:50%
Tetrahedron Letters          2003          44          7541-7544
Formation of (E) 1-alkoxy-1,3-butadienes from corresponding propargyl ethers; vicarious nucleophilic substitution in alkoxyallenes
Robert Łysek, Ewa Woźny, Tong Thanh Danh, Marek Chmielewski
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
15 .     (¡À)-methyl 2-hydroxy-2-azabicyclo[2.2.1]hept-5-ene-3-exo-carboxylate
C8H11NO3     ÏàËÆ¶È:50%
Tetrahedron          2012          68          1682-1687
1,3- versus 1,4-[¦Ð4+¦Ð2] Cycloadditions between methyl glyoxylate oxime and cyclopentadiene or cyclopentene
Carlos A.D. Sousa, M. Lu¨ªsa C. Vale, Xerardo Garcia-Mera, Jos¨¦ E. Rodr¨ªguez-Borges
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
16 .     N-methyl-1-[1-(2-(2-methyl-5-nitro-1H-imidazole-1-yl)ethyl)-1H-1,2,3-triazole-4-yl]methylamine
    ÏàËÆ¶È:50%
Bioorganic & Medicinal Chemistry          2012          20          4040-4048
Influence of ligand denticity on the properties of novel 99mTc(I)¨Ccarbonyl complexes. Application to the development of radiopharmaceuticals for imaging hypoxic tissue
Soledad Fern¨¢ndez, Javier Giglio, Ana M. Rey, Hugo Cerecetto
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
17 .     O-ethyl 2-thenoylthiocarbamate
C8H9NO2S2     ÏàËÆ¶È:50%
Tetrahedron          2012          68          9384-9390
Three practical approaches for the synthesis of novel 4,7-dihetarylpyrazolo[1,5-a][1,3,5]triazines
Henry Insuasty, Braulio Insuasty, Edison Castro, Jairo Quiroga, Rodrigo Abon¨ªa, Manuel Nogueras, Justo Cobo
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
18 .     1-(2-nitro-1H-imidazolyl)-3-(2-methyl-5-nitro-1H-imidazolyl)propan-2-ol
C10H12N6O5     ÏàËÆ¶È:50%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
19 .     N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]trifluoroacetamide
C8H9F3N4O3     ÏàËÆ¶È:50%
Journal of Medicinal Chemistry          1995          38          1928-1941
Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility
Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
20 .     5-ethyl-4-methyl-3-hydroxypyridine
C8H11NO     ÏàËÆ¶È:50%
Chemical Research in Toxicology          2003          16          232-241
Model Studies on the Modification of Proteins by Lipoxidation-Derived 2-Hydroxyaldehydes
Zhongfa Liu and Lawrence M. Sayre
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
3Â¥2013-12-12 22:05:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ haoyumomo µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 280Çóµ÷¼Á +5 Àîrien 2026-04-04 5/250 2026-04-06 23:01 by chenzhimin
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£ÖÝ´óѧ085600Çóµ÷¼Á +19 ³ÔµÄ²»ÉÙ 2026-04-05 22/1100 2026-04-06 22:39 by tianyyysss
[¿¼ÑÐ] 273Çóµ÷¼Á +20 ÂóС¶£µ± 2026-04-06 23/1150 2026-04-06 22:22 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ÉúÎïѧÇóµ÷¼Á Ò»Ö¾Ô¸»¦9£¬326·Ö +6 Áõīī 2026-04-06 6/300 2026-04-06 19:36 by lijunpoly
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +12 Ò»ÑùYWY 2026-04-05 13/650 2026-04-06 15:38 by lin-da
[¿¼ÑÐ] 070300»¯Ñ§279Çóµ÷¼Á +16 ¹þ¹þ¹þ^_^ 2026-03-31 19/950 2026-04-06 14:14 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Ò»Ö¾Ô¸Î人Àí¹¤´óѧ-085601²ÄÁϹ¤³Ì£¨×¨Ë¶£©-×Ü·Ö353Çóµ÷¼Á +3 2626262626li 2026-04-02 3/150 2026-04-06 09:08 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©½»Í¨´óѧ²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +4 cs0106 2026-04-04 4/200 2026-04-05 18:46 by imissbao
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +13 Ò»ÑùYWY 2026-04-03 14/700 2026-04-05 18:20 by À¶ÔÆË¼Óê
[¿¼ÑÐ] µç×ÓÐÅÏ¢µ÷¼Á½»²æÑ§¿ÆÓÐÍÆ¼öÂð +6 jhtfeybgj 2026-04-01 9/450 2026-04-05 11:13 by Öí»á·É
[¿¼ÑÐ] 413Çóµ÷¼Á +4 ¿Âijij 2026-03-31 4/200 2026-04-04 22:18 by ѧԱ6BFVa3
[¿¼ÑÐ] ±¾¿Æ211£¬×¨Òµ085404£¬293·ÖÇëÇóµ÷¼Á +5 Á«²Ë¾ÍÊÇź°É 2026-04-04 5/250 2026-04-04 14:08 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] 387Çóµ÷¼Á +4 °®³ÔƬ¶¹ÍÁ 2026-04-03 5/250 2026-04-04 08:10 by °¶ÉϵÄÒ»ÌõÓã
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸±±¾©ÖÐÒ½Ò©´óѧ +3 СС´ï²»Áï 2026-04-02 3/150 2026-04-03 22:55 by ³åʸêÄÐÇÍÅ
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +5 ´Þwj 2026-04-03 5/250 2026-04-03 15:06 by arrow8852
[¿¼ÑÐ] 338Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄÜÔ´¶¯Á¦£¬ÍâÓïÊÇÈÕÓï203 +5 zzz£¬£¬r 2026-04-02 5/250 2026-04-03 09:45 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸Éî´ó085601²ÄÁϹ¤³Ìרҵ£¨×¨Ë¶£©300·Ö¿ÉÒÔµ÷¼ÁÈ¥ÄÄ +8 10160315 2026-04-02 8/400 2026-04-03 09:36 by hypershenger
[¿¼ÑÐ] 293Çóµ÷¼Á +4 çæçæÀÖ 2026-04-02 4/200 2026-04-02 20:10 by 6781022
[˶²©¼ÒÔ°] ¿¼Ñе÷¼Á +5 ÂæÍÕÄÐÈË 2026-04-01 5/250 2026-04-01 14:28 by syjjj0321
[¿¼ÑÐ] ¡¾µ÷¼Á¡¿Ò»Ö¾Ô¸ÏôóÉúÎïÓëÒ½Ò©µ÷¼Á +3 EchoϺÃ× 2026-03-31 3/150 2026-04-01 08:40 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û